Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating cytokine-induced killer cells for metastatic urogenital tumors (bladder and renal cancer) is ongoing b…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC [Phase 2]
Phase 2 study evaluating safety and efficacy of tislelizumab plus axitinib as neoadjuvant therapy for clear cell renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564) [Phase 3]
Phase 3 trial assessing pembrolizumab as adjuvant therapy after nephrectomy in renal cell carcinoma has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-12-23Clinical Trial Update: Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5 [Phase 2]
Phase 2 clinical trial update for second-line pazopanib in renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Clinical trial update reporting complete responses to sunitinib in Spanish patients with metastatic renal cell carcinoma; results posted fro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC [Phase 1, Phase 2]
Phase 1/2 study of tivozanib in combination with nivolumab in renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating various sunitinib schedules in kidney cancer (renal cell carcinoma), status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial exploring the combination of anlotinib and everolimus as first-line treatment for advanced non-clear cell renal cell …
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment
A completed clinical trial evaluating fatigue- and hand-foot syndrome-related quality of life in patients with metastatic renal cell carcino…
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted Therapies [Phase 3]
Phase 3 trial update on systemic treatments for bone metastases in metastatic renal cell carcinoma patients treated with targeted therapies;…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer [Phase 4]
Phase 4 trial updating safety of nivolumab plus ipilimumab in previously untreated advanced or metastatic renal cell carcinoma; results post…
-
CLINICAL_TRIALS trial_result · 2021-10-06Clinical Trial Update: Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen [Phase 2]
A Phase 2 clinical trial evaluating nivolumab in patients with metastatic renal cell carcinoma who progressed during or after anti-angiogeni…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 study results for INCB001158, an arginase inhibitor, as a single agent and in combination with immune checkpoint therapy, in patient…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma [Phase 3]
Phase 3 clinical trial update comparing lenvatinib plus everolimus or lenvatinib plus pembrolizumab versus sunitinib alone in advanced renal…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers [Phase 2]
Phase II randomized trial assessing immunotherapy plus radiotherapy in metastatic genitourinary cancers; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) [Phase 2]
Phase 2 trial comparing pazopanib to temsirolimus in poor-risk clear-cell renal cell carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases [Phase 2]
A Phase 2 trial evaluating sorafenib efficacy in renal cell carcinoma patients after radical resection of metastases is in development, with…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Robotic-assisted vs. Open Partial Nephrectomy [Phase 2]
Phase 2 clinical trial comparing robotic-assisted to open partial nephrectomy for renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients [Phase 2]
Phase 2 trial evaluating pembrolizumab with SBRT in patients with stage IV renal cell cancer (AJCC 7th edition) has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab plus axitinib as neoadjuvant therapy for locally advanced non-metastatic clear cell renal ce…
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer [Phase 2]
Phase 2 trial evaluating sintilimab in combination with axitinib for advanced renal cell carcinoma, including clear cell histology.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion [Phase 2]
Phase 2 trial evaluating axitinib for reducing extent of venous tumor thrombus in renal cell carcinoma with venous invasion has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma [Phase 1]
Phase 1 study assessing safety and functional imaging of cG250 with sunitinib in advanced renal cell carcinoma was terminated; results poste…
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma [Phase 4]
Phase 4 clinical trial update for Aldesleukin in participants with metastatic renal cell carcinoma or metastatic melanoma has completed with…